Risk factors for subclinical hypothyroidism in pregnant women in the 24 de Mayo canton, Ecuador
DOI:
https://doi.org/10.56294/hl2024.40Keywords:
Hypothyroidism, pregnant, determinants, EcuadorAbstract
Subclinical hypothyroidism during pregnancy is characterized by an increase in TSH with normal levels of T3 and T4, which can lead to complications if not diagnosed in time. In Canton 24 de Mayo, Ecuador, the identification of this condition in pregnant women is affected by several risk factors. Among these factors are the lack of access to accessible diagnostic tests, the general lack of knowledge about thyroid diseases, and the lack of health education programs that adequately address the issue. Underdiagnosis is a critical problem in this area, mainly due to the absence of regular screening during prenatal control. This study highlights the urgent need to implement policies that improve access to thyroid testing and promote education on the importance of early diagnosis, especially in vulnerable populations such as pregnant women.
References
Aguirre Luzuriaga, N. N. (2024). Conducta Preventiva Y Manejo Terapéutico De La Tormenta Tiroidea En La Actualidad. https://repositorio.utmachala.edu.ec/handle/48000/23114
Anaforoğlu İ, Algün E, İnceçayir Ö, Topbaş M, Erdoğan Mf. Iodine Status Among Pregnant Women After Mandatory Salt Iodisation. British Journal Of Nutrition. 2016;115(3):405-410. https://doi.org/10.1017/s0007114515004559
Castillo, A. Á., Alfaro, J. M. R., & Boza, A. S. (2020). Abordaje Del Hipotiroidismo Subclínico En El Adulto. Revista Médica Sinergia, 5(02), 358-358. https://doi.org/10.31434/rm s.v5i2.358
Dhillon-Smith, R. K., Middleton, L. J., Sunner, K. K., Cheed, V., Baker, K., Farrell-Carver, S., Bender-Atik, R., Agrawal, R., Bhatia, K., Edi-Osagie, E., Ghobara, T., Gupta, P., Jurkovic, D., Khalaf, Y., MacLean, M., McCabe, C., Mulbagal, K., Nunes, N., Overton, C. Coomarasamy, A. (2019). Levothyroxine in women with thyroid peroxidase antibodies before conception. The New England Journal of Medicine, 380(14), 1316–1325. https://doi.org/10.1056/nejmoa1812537
Fuentes Rodríguez, N, Gaona Torres, K, Marquez Miranda, M, Narváez Mancilla, L y Pinto Murillo, D. (2024). Prevalencia del hipotirodismo subclínico en gestantes de una Clínica en Soacha, Colombia entre el periodo enero a diciembre del 2023. Fundación Universitaria Juan N. Corpas. https://repositorio.juanncorpas.edu.co/handle/001/262
Gavoto, L. (2022). ¿El tratamiento del hipotiroidismo subclínico tiene efecto sobre la morbimortalidad cardiovascular?. Evidencia - Actualizacion En La práctica Ambulatoria, 25(1), e002087. https://doi.org/10.51987/evidencia.v25i2.7008
Pablo, M. H. E. (2024, 10 julio). Hiperlipidemia y disfunción tiroidea subclínica en mujeres mayores de 30 años en un consultorio privado en Huancayo 2020 - 2022. https://repositorio.upla.edu.pe/handle/20.500.12848/7812?show=full
Kim, C.-H., Ahn, J.-W., Kang, S. P., Kim, S.-H., Chae, H.-D., & Kang, B.-M. (2011). Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility, 95(5), 1650–1654. https://doi.org/10.1016/j.fertnstert.2010.12.004
Nazarpour, S., Ramezani Tehrani, F., Simbar, M., Tohidi, M., Alavi Majd, H., & Azizi, F. (2017). Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. European Journal of Endocrinology, 176(2), 253–265. https://doi.org/10.1530/eje-16-0548
Siscart, J., Perejón, D., Serna, M. C., Oros, M., Godoy, P., & Sole, E. (2023). Prevalence, risk factors, and consequences of hypothyroidism among pregnant women in the health region of Lleida: A cohort study. PLoS ONE, 18(10), e0278426. https://doi.org/10.1371/journal.pone.0278426
Urgatz, B., & Razvi, S. (2023). Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature. Current Medical Research and Opinion, 39(3), 351–365. https://doi.org/10.1080/03007995.2023.2165811
Van Dijk, M. M., Vissenberg, R., Fliers, E., Van Der Post, J. A. M., Van Der Hoorn, M. P., De Weerd, S., Kuchenbecker, W. K., Hoek, A., Sikkema, J. M., Verhoeve, H. R., Broeze, K. A., De Koning, C. H., Verpoest, W., Christiansen, O. B., Koks, C., De Bruin, J. P., Papatsonis, D. N. M., Torrance, H., Van Wely, M., Goddijn, M. (2022). Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Diabetes & Endocrinology, 10(5), 322-329. https://doi.org/10.1016/s2213-8587(22)00045-6
Wang, H., Gao, H., Chi, H., Zeng, L., Xiao, W., Wang, Y., Li, R., Liu, P., Wang, C., Tian, Q., Zhou, Z., Yang, J., Liu, Y., Wei, R., Mol, B. W. J., Hong, T., & Qiao, J. (2017). Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer. JAMA, 318(22), 2190. https://doi.org/10.1001/jama.2017.18249.
Published
Issue
Section
License
Copyright (c) 2024 Ariana C. Fallaín, Angela J. Macías, John Ch. López, Danna M. Cedeño, Patricio J. Chimbo, José A. Cedeño (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
